Literature DB >> 25366393

Induced mild systemic inflammation is associated with impaired ability to improve cognitive task performance by practice.

Nicola J Paine1, Jos A Bosch, Christopher Ring, Mark T Drayson, Jet J C S Veldhuijzen van Zanten.   

Abstract

Elevated inflammatory levels are linked to poorer cognition, but experimental confirmation is lacking. This report examined associations between cognitive performance and inflammation induced by exercise and vaccination. Thirty-six (exercise N = 18, vaccination N = 18) healthy males completed a paced auditory serial addition test (PASAT), which is a multifaceted measure of cognitive function. The task was completed in placebo and elevated inflammation states. Improvements in PASAT performance were related to inflammation. In the exercise study, IL-6 during the first PASAT negatively correlated with PASAT improvement (p = .022). In the vaccination study, increases in C-reactive protein between PASATs correlated with reduced PASAT improvement (p < .001). Inflammation was linked to reduced improvements in cognitive performance. Further research should identify the specific cognitive functions affects and the underlying mechanisms.
© 2014 Society for Psychophysiological Research.

Entities:  

Keywords:  Cognitive function; Eccentric exercise; Inflammation; PASAT; Vaccination

Mesh:

Substances:

Year:  2014        PMID: 25366393     DOI: 10.1111/psyp.12360

Source DB:  PubMed          Journal:  Psychophysiology        ISSN: 0048-5772            Impact factor:   4.016


  7 in total

1.  Investigating whether depressed youth exhibiting elevated C reactive protein perform worse on measures of executive functioning, verbal fluency and episodic memory in a large, population based sample of Dutch adolescents.

Authors:  Naoise Mac Giollabhui; Lauren B Alloy; Catharina A Hartman
Journal:  Brain Behav Immun       Date:  2020-09-02       Impact factor: 7.217

2.  The effects of a psychological intervention directed at optimizing immune function: study protocol for a randomized controlled trial.

Authors:  Lemmy Schakel; Dieuwke S Veldhuijzen; Henriët van Middendorp; Corine Prins; Simone A Joosten; Tom H M Ottenhoff; Leo G Visser; Andrea W M Evers
Journal:  Trials       Date:  2017-05-26       Impact factor: 2.279

3.  An Internet-Based Psychological Intervention With a Serious Game to Improve Vitality, Psychological and Physical Condition, and Immune Function in Healthy Male Adults: Randomized Controlled Trial.

Authors:  Lemmy Schakel; Dieuwke S Veldhuijzen; Henriët van Middendorp; Corine Prins; Anne M H F Drittij; Frank Vrieling; Leo G Visser; Tom H M Ottenhoff; Simone A Joosten; Andrea W M Evers
Journal:  J Med Internet Res       Date:  2020-07-24       Impact factor: 5.428

4.  Biochemical clusters predict mortality and reported inability to work 10 ​years later.

Authors:  Nina Bertele; Alexander Karabatsiakis; Anat Talmon; Claudia Buss
Journal:  Brain Behav Immun Health       Date:  2022-02-25

5.  Inflammatory Blood Biomarker Kynurenine Is Linked With Elevated Neuroinflammation and Neurodegeneration in Older Adults: Evidence From Two 1H-MRS Post-Processing Analysis Methods.

Authors:  Wouter A J Vints; Simona Kušleikiene; Samrat Sheoran; Milda Šarkinaite; Kristina Valatkevičiene; Rymante Gleizniene; Mindaugas Kvedaras; Kazimieras Pukenas; Uwe Himmelreich; Vida J Cesnaitiene; Oron Levin; Jeanine Verbunt; Nerijus Masiulis
Journal:  Front Psychiatry       Date:  2022-04-11       Impact factor: 5.435

6.  The association of high sensitivity C-reactive protein and incident Alzheimer disease in patients 60 years and older: The HUNT study, Norway.

Authors:  Jessica Mira Gabin; Ingvild Saltvedt; Kristian Tambs; Jostein Holmen
Journal:  Immun Ageing       Date:  2018-01-22       Impact factor: 6.400

7.  The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study.

Authors:  Riccardo De Giorgi; Marieke Martens; Nicola Rizzo Pesci; Philip J Cowen; Catherine J Harmer
Journal:  J Psychopharmacol       Date:  2021-12       Impact factor: 4.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.